Search Results - "Gianfaldoni, Giacomo"
-
1
Management of Paroxysmal Nocturnal Haemoglobinuria: a personal view
Published in British journal of haematology (01-06-2011)“…Summary Paroxysmal nocturnal haemoglobinuria (PNH) is a serious form of acquired haemolytic anaemia with several features that make it unique, including the…”
Get full text
Journal Article -
2
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
Published in Blood (30-04-2009)“…Clinical risk classification is inaccurate in predicting relapse in adult patients with acute lymphoblastic leukemia, sometimes resulting in patients receiving…”
Get full text
Journal Article -
3
Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting
Published in Haematologica (Roma) (05-09-2024)“…Not available.Not available…”
Get full text
Journal Article -
4
-
5
Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab
Published in Blood (23-04-2009)“…In paroxysmal nocturnal hemoglobinuria (PNH) hemolytic anemia is due mainly to deficiency of the complement regulator CD59 on the surface of red blood cells…”
Get full text
Journal Article -
6
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia
Published in Haematologica (Roma) (01-01-2024)“…Measurable residual disease (MRD) is a powerful predictor of outcome in acute myeloid leukemia. In the early phases of treatment, MRD refines initial disease…”
Get full text
Journal Article -
7
CEBPA -double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features
Published in Haematologica (Roma) (01-03-2017)“…Mutations in CCAAT/enhancer binding protein α ( ) occur in 5-10% of cases of acute myeloid leukemia. -double-mutated cases usually bear biallelic N- and…”
Get full text
Journal Article -
8
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
Published in Haematologica (Roma) (27-08-2020)“…Secondary acute myeloid leukemia (sAML) after myelodysplastic or myeloproliferative disorders is a high-risk category currently identified by clinical history…”
Get full text
Journal Article -
9
Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria
Published in International journal of hematology (01-08-2006)“…The unique feature of paroxysmal nocturnal hemoglobinuria (PNH), a chronic disease with severe hemolytic anemia, is the presence of a population of blood cells…”
Get full text
Journal Article -
10
Successful rechallenge with Erwinia chrysanthemi asparaginase after pegaspargase-induced hypertriglyceridemia: a case report
Published in Therapeutic advances in hematology (01-01-2024)“…Polyethylene-glycolated -derived l-asparaginase (pegaspargase, pASP) is an essential component of paediatric-inspired regimens for the treatment of acute…”
Get full text
Journal Article -
11
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program
Published in Haematologica (Roma) (01-11-2013)“…We evaluate the long-term results of a prospective clinical study enrolling more than 100 adult patients with Burkitt lymphoma/leukemia. Depending on extent of…”
Get full text
Journal Article -
12
-
13
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia
Published in Cytometry. Part B, Clinical cytometry (01-09-2014)“…Background In acute myeloid leukemia (AML), CXCR4 expression has been correlated with leukocytosis and prognosis. Methods We quantified CXCR4 expression by…”
Get full text
Journal Article -
14
Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia
Published in Haematologica (Roma) (01-05-2010)“…We investigated the prognostic significance of early peripheral blast clearance as assessed by WT1 transcript reduction during the first days of standard…”
Get full text
Journal Article -
15
Peripheral blood blast clearance during induction therapy in acute myeloid leukemia
Published in Blood (01-02-2008)Get full text
Journal Article -
16
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease
Published in Haematologica (Roma) (01-04-2012)“…The prognostic significance of CD20 expression in acute lymphoblastic leukemia has been investigated in children and adults but is still a subject of debate…”
Get full text
Journal Article -
17
APL-like Subset within NPM1-Mutated Acute Myeloid Leukemia: A Distinct Phenotypic Signature Correlating with Early-Onset Vascular Complications
Published in Blood (02-11-2023)“…Background:NPM1 mutations represent the most common genetic alteration in adult acute myeloid leukemia (AML), often in co-occurrence with FLT3-ITD and…”
Get full text
Journal Article -
18
-
19
The Impact of Baseline Genetic Profile and Treatment on Hematological Toxicity in CEBPA-Mutated Acute Myeloid Leukemia
Published in Blood (02-11-2023)“…Background:CEBPA-mutated acute myeloid leukemia (AML) is a separate entity in the updated WHO and ICC classifications. Previously identified by double…”
Get full text
Journal Article -
20
Selected Genomic Structural Variants Refine ELN-Based Prognostic Stratification of Patients with Acute Myeloid Leukemia and Normal Karyotype
Published in Blood (02-11-2023)“…Background. Normal karyotype Acute Myeloid Leukemia (nk-AML) accounts for 40% of all AML. Conventionally, nk-AML patients (pts) have been associated with the…”
Get full text
Journal Article